Dear Editor-in-Chief
====================

*Aspergillus fumigatus*, a saprophytic airborne fungus, is mentioned as the most common invasive mold with mortality rates exceeds 50% in high-risk groups. Recently, with increases in the number of immunocompromised individuals, there has been a noticeable increase in the rate of invasive aspergillosis ([@B1]--[@B3]).

Translation elongation factors (EFs) are molecules for protein synthesis on ribosome. These molecules bind guanine nucleotides and in its GTP-liganded form can interact with aminoacyl tRNA to bring it to the A-site of the ribosome. Following hydrolysis of the GTP, EF-1, GDP is released from the ribosome. The activity and regulation of EF-1 *a* are expressed developmentally and that this regulation occurs at severa1 levels ([@B4]). Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID) and is widely used for treatment of inflammatory disease ([@B5]). Additionally, anti-microbial effects of this drug have been documented in previous studies ([@B6], [@B7]). Inhibitory effects of this drug occurred by interfering in prostaglandin biosynthesis ([@B8]).

In the present study, antifungal activity of diclofenac sodium was investigated against hyphae formation in *A. fumigatus* with special attentions to the expression of EF-1gene.

To determine the minimum inhibitory concentration (MIC), the standard strain of *A. fumigatus* (ATCC 14489) was cultured 48 h at 35 °C in sabouraud dextrose agar medium. Inoculum suspensions were prepared by scraping the surface of colonies with a loop on sterile Tris-EDTA buffer with Tween 40 (0.05%). Spore suspension was then prepared at concentration of 5×10^4^ CFU ml^−1^ using hemocytometer method. Afterward, the suspension was treated with different concentrations of diclofenac sodium (25--900 μg/ml). Microplates (24 holes) were determined according to recommendations stated in the CLSI M38-A2 document ([@B9]). Fungal suspensions treated by diclofenac sodium alone (control positive) and untreated (Control negative) have also been considered. Finally, the cultured microplates incubated at 35 °C for 48 h. To investigate the level of EF-1 gene expression in *A. fumigatus*, a quantitative Real-time PCR was performed. Briefly, cultured *A. fumigatus* cells in the presence of 500, 700, 900 μg/ml of diclofenac sodium as well as treated (Control+) and untreated (Control−) fungal cells with diclofenac were considered. After incubation period, the harvested mycelia mass washed by phosphate buffer saline (PBS) 1X and grinded by liquid nitrogen to gain a fine mycelial powder. The obtained mycelial powder was used for RNA extraction by Guanidine Isothiocyanate method (GITC) ([@B10]). cDNA molecules were prepared by using random hexamer primers and reverse transcriptase enzyme, according to the defined protocol (RevertAid, Fermentase, Germany). Pairs of primer for amplification of EF-1 gene and β-actin gene (as housekeeping gene) were designed and synthesized (Sinaclone, Iran). Real-time PCR was carried out in order to comparison between levels of EF-1 mRNA as well as β-actin mRNA in treated and untreated cells. Operational program for amplification cycles was 95 °C 30 sec as initial denaturation, followed by 40 cycles of 95 °C for 10 sec, 60 °C for 30 sec. Real-time PCR system (StepOne-Plus TM, Applied Biosystems, USA) and Syber Green I dye (SYBR® Premix Ex Taq™ II) were used in this investigation.

By increasing of diclofenac sodium concentration, mycelium production have been decreased and deviation seen in their normal shape. Drug treatment in concentration of 500 μg/ml and more have indicated a significant inhibitory effect on the *A. fumigatus* growth ([Fig. 1](#F1){ref-type="fig"}). In addition, measured levels of EF-1 mRNA in diclofenac treated and untreated cells revealed higher expression in untreated control cells (27.7) compared with fungal cells treated with 900 μg/ml of diclofenac (0.672) after normalization to β-actin ([Table 1](#T1){ref-type="table"}). Diclofenac can decrease the EF-1 gene expression. Diclofenac sodium, with a dose-dependent effect, can significantly reduce both; the production of mycelia and EF-1 gene expression in *A. fumigatus*.
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###### 

Comparison of EF-1 Gene expression in untreated control *A. fumigatus* mycelial cells (A) and *A. fumigatus* mycelial cells treated with 900 μg/ml diclofenac sodium (D)

  ***Gene***   ***Type***   ***Reaction Efficiency***   ***Expression***   ***Std. Error***   ***95% C.I.***     ***P(H1)***   ***Result***
  ------------ ------------ --------------------------- ------------------ ------------------ ------------------ ------------- --------------
  1            REF          0.695                       1.000                                                                  
  2            EF1 (A)      0.65                        27.770             27.770 -- 27.770   27.770 -- 27.770   0.000         UP
  4            EF1 (D)      0.57                        0.672              0.672 -- 0.672     0.672 -- 0.672     0.000         DOWN

We suggest the performance of more clinical studies for validation possible usage of diclofenac sodium in order to treat aspergillosis infection.
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